These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 203543

  • 1. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N, Boone CW, Holden HT, Herberman RB.
    Int J Cancer; 1978 Jan 15; 21(1):78-84. PubMed ID: 203543
    [Abstract] [Full Text] [Related]

  • 2. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM, Prehn RT.
    J Natl Cancer Inst; 1978 Nov 15; 61(5):1323-7. PubMed ID: 213613
    [Abstract] [Full Text] [Related]

  • 3. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun 15; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 4. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP, Leclerc JC.
    Adv Cancer Res; 1977 Jun 15; 24():1-66. PubMed ID: 66859
    [No Abstract] [Full Text] [Related]

  • 5. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M, Pearson G, Redmon L, Winters E, Kasuga S.
    J Immunol; 1975 Apr 15; 114(4):1318-22. PubMed ID: 1090675
    [Abstract] [Full Text] [Related]

  • 6. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB, Knight RA.
    Br J Cancer; 1975 May 15; 31(5):499-512. PubMed ID: 50852
    [Abstract] [Full Text] [Related]

  • 7. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A.
    J Natl Cancer Inst; 1978 Sep 15; 61(3):885-90. PubMed ID: 80457
    [Abstract] [Full Text] [Related]

  • 8. Isotype distribution and specificity of the antibody response to primary Moloney murine sarcoma virus infection in BALB/c mice.
    Powell TJ, Gaupp B, Epps JM, Srinivas RV, Lamon EW.
    Viral Immunol; 1989 Sep 15; 2(2):89-101. PubMed ID: 2673279
    [Abstract] [Full Text] [Related]

  • 9. Moloney sarcoma virus-induced tumors in athymic (nude) mice: growth pattern and antibody responses.
    Davis S.
    J Natl Cancer Inst; 1975 Mar 15; 54(3):793-4. PubMed ID: 164570
    [Abstract] [Full Text] [Related]

  • 10. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
    Becker S, Haskill S.
    J Natl Cancer Inst; 1980 Aug 15; 65(2):469-75. PubMed ID: 6249952
    [Abstract] [Full Text] [Related]

  • 11. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec 15; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of Moloney murine sarcoma and leukemia virus complex as a model for airborne oncogenic virus biohazards: survival of airborne virus and exposure of mice.
    Hinshaw VS, Schaffer FL, Chatigny MA.
    J Natl Cancer Inst; 1976 Oct 15; 57(4):775-8. PubMed ID: 187776
    [Abstract] [Full Text] [Related]

  • 14. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E, Leclerc JC, Levy JP.
    J Natl Cancer Inst; 1973 Apr 15; 50(4):955-61. PubMed ID: 4122212
    [No Abstract] [Full Text] [Related]

  • 15. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW, Powell TJ, Walia AS, Lidin BI, Srinivas RV, Baskin JG, Kearney JF.
    J Natl Cancer Inst; 1987 Mar 15; 78(3):547-56. PubMed ID: 3469466
    [Abstract] [Full Text] [Related]

  • 16. Lack of M-MuSV tumour regression associated with T lymphocyte tolerance.
    Chieco-Bianchi L, Collavo D, Zanovell P, De Rossi A, Davies AJ.
    Nature; 1980 Jun 26; 285(5767):667-8. PubMed ID: 6248790
    [No Abstract] [Full Text] [Related]

  • 17. Role of infectious virus expression and immune response in retrovirus-induced oncogenesis.
    Zanovello P, D'Andrea E, Ronchese F, De Rossi A, Collavo D, Chieco-Bianchi L.
    Tumori; 1984 Feb 29; 70(1):1-8. PubMed ID: 6324431
    [Abstract] [Full Text] [Related]

  • 18. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW, Anderson B, Wigzell H, Fenyö EM, Klein E.
    Int J Cancer; 1974 Jan 15; 13(1):91-104. PubMed ID: 4594340
    [No Abstract] [Full Text] [Related]

  • 19. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL.
    J Natl Cancer Inst; 1983 Mar 15; 70(3):493-7. PubMed ID: 6572738
    [Abstract] [Full Text] [Related]

  • 20. Transformation of horse skin cells by type-C sarcoma viruses.
    Rhim JS, Ro HS, Kim EB, Gilden RV, Huebner RJ.
    Int J Cancer; 1975 Feb 15; 15(2):171-9. PubMed ID: 165152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.